AR010337A1 - ISOLATED NUCLEIC ACID, NUCLEIC ACID MOLECULA, PROBE, RECOMBINANT EXPRESSION VECTOR, CELL, METHOD FOR PRODUCING A POLYPEPTIDE OF H.PYLORI, METHOD FOR DETECTING THE PRESENCE OF A NUCLEIC ACID HELICOBACTER, POLIPE FORMULATION FOR VACCINE - Google Patents
ISOLATED NUCLEIC ACID, NUCLEIC ACID MOLECULA, PROBE, RECOMBINANT EXPRESSION VECTOR, CELL, METHOD FOR PRODUCING A POLYPEPTIDE OF H.PYLORI, METHOD FOR DETECTING THE PRESENCE OF A NUCLEIC ACID HELICOBACTER, POLIPE FORMULATION FOR VACCINEInfo
- Publication number
- AR010337A1 AR010337A1 ARP970105740A ARP970105740A AR010337A1 AR 010337 A1 AR010337 A1 AR 010337A1 AR P970105740 A ARP970105740 A AR P970105740A AR P970105740 A ARP970105740 A AR P970105740A AR 010337 A1 AR010337 A1 AR 010337A1
- Authority
- AR
- Argentina
- Prior art keywords
- nucleic acid
- pylori
- polypeptide
- producing
- vaccine
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 7
- 108020004707 nucleic acids Proteins 0.000 title abstract 7
- 150000007523 nucleic acids Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 5
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000589989 Helicobacter Species 0.000 title abstract 2
- 239000013604 expression vector Substances 0.000 title abstract 2
- 238000003259 recombinant expression Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un ácido nucleico aislado que comprende una secuencia nucleotídica que codifica un polipéptido de H.pylori que es por lo menos aproximadamente 60%homologa con una secuencia de animoácido seleccionada del grupo que consiste en SEC ID N* 98-SECID N* 194; ácido nucleico aislado, molécula de ácido nucleico,sonda, vector de expresion recombinante, célula, método para producir un polipéptido de H. Pylori, método para detectar la presencia de un ácidonucleico helicobacter, polipéptidode H . pylori aislado, proteína de fusion, formulacion para vacuna para tratamiento profiláctico o terapéutico de unainfeccion de H.pylori, método para tratar o reducir un riesgo de contraer la infeccion de H,pylori, método para producir unaformula cion para vacuna ypolipéptido de H.pylori quimérico.An isolated nucleic acid comprising a nucleotide sequence encoding an H.pylori polypeptide that is at least about 60% homologous to an amino acid sequence selected from the group consisting of SEQ ID N * 98-SECID N * 194; isolated nucleic acid, nucleic acid molecule, probe, recombinant expression vector, cell, method of producing an H. pylori polypeptide, method of detecting the presence of a helicobacter nucleic acid, H polypeptide. isolated pylori, fusion protein, vaccine formulation for prophylactic or therapeutic treatment of H. pylori infection, method of treating or reducing a risk of contracting H infection, pylori, method of producing a formulation for H.pylori vaccine and polypeptide chimerical.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75962596A | 1996-12-05 | 1996-12-05 | |
| US82374597A | 1997-03-25 | 1997-03-25 | |
| US89192897A | 1997-07-14 | 1997-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010337A1 true AR010337A1 (en) | 2000-06-07 |
Family
ID=27419527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105740A AR010337A1 (en) | 1996-12-05 | 1997-12-05 | ISOLATED NUCLEIC ACID, NUCLEIC ACID MOLECULA, PROBE, RECOMBINANT EXPRESSION VECTOR, CELL, METHOD FOR PRODUCING A POLYPEPTIDE OF H.PYLORI, METHOD FOR DETECTING THE PRESENCE OF A NUCLEIC ACID HELICOBACTER, POLIPE FORMULATION FOR VACCINE |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0964699A4 (en) |
| JP (1) | JP2001510992A (en) |
| KR (1) | KR20000069297A (en) |
| CN (1) | CN1246799A (en) |
| AR (1) | AR010337A1 (en) |
| AU (1) | AU739641B2 (en) |
| BR (1) | BR9714133A (en) |
| CA (1) | CA2273199A1 (en) |
| EE (1) | EE9900226A (en) |
| ID (1) | ID21946A (en) |
| IL (1) | IL129746A0 (en) |
| IS (1) | IS5047A (en) |
| NO (1) | NO992158L (en) |
| NZ (1) | NZ335633A (en) |
| PL (1) | PL333943A1 (en) |
| SK (1) | SK57999A3 (en) |
| TR (1) | TR199901262T2 (en) |
| WO (1) | WO1998024475A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000024883A1 (en) * | 1998-10-26 | 2000-05-04 | Novozymes A/S | Constructing and screening a dna library of interest in filamentous fungal cells |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| US6951729B1 (en) | 1999-10-27 | 2005-10-04 | Affinium Pharmaceuticals, Inc. | High throughput screening method for biological agents affecting fatty acid biosynthesis |
| WO2002031128A1 (en) * | 2000-10-06 | 2002-04-18 | Smithkline Beecham Corporation | Methods of agonizing and antagonizing fabk |
| US7048926B2 (en) | 2000-10-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Methods of agonizing and antagonizing FabK |
| WO2002066502A1 (en) * | 2001-02-21 | 2002-08-29 | Boren Thomas | Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| EP2344152A4 (en) * | 2008-10-08 | 2013-04-03 | Immune Solutions Ltd | Oral vaccines for producing mucosal immunity |
| JP6959937B2 (en) * | 2015-12-14 | 2021-11-05 | テクニシェ ユニバーシタット ミュンヘン | Helicobacter pylori vaccine |
| CN110343697B (en) * | 2019-08-05 | 2024-07-12 | 南京昊斯亭网络科技有限公司 | Method for extracting total DNA of plant disease bacteria |
| CN113435168B (en) * | 2021-06-10 | 2024-03-22 | 上海美吉生物医药科技有限公司 | Automatic editing method, system, terminal and medium for glue pattern |
| CN114057854B (en) * | 2021-09-30 | 2022-07-15 | 河北医科大学第四医院 | Helicobacter pylori CD4+T cell tolerance polypeptide fusion antigen and application thereof |
| CN116162140A (en) * | 2022-07-19 | 2023-05-26 | 四川大学华西医院 | Helicobacter pylori recombinant antigen protein SecG, and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (en) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Preparation of a new drug |
-
1997
- 1997-12-05 KR KR1019997004955A patent/KR20000069297A/en not_active Application Discontinuation
- 1997-12-05 TR TR1999/01262T patent/TR199901262T2/en unknown
- 1997-12-05 CN CN97181630A patent/CN1246799A/en active Pending
- 1997-12-05 AU AU58954/98A patent/AU739641B2/en not_active Ceased
- 1997-12-05 SK SK579-99A patent/SK57999A3/en unknown
- 1997-12-05 WO PCT/US1997/022104 patent/WO1998024475A1/en not_active Application Discontinuation
- 1997-12-05 IL IL12974697A patent/IL129746A0/en unknown
- 1997-12-05 ID IDW990495A patent/ID21946A/en unknown
- 1997-12-05 PL PL97333943A patent/PL333943A1/en unknown
- 1997-12-05 CA CA002273199A patent/CA2273199A1/en not_active Abandoned
- 1997-12-05 NZ NZ335633A patent/NZ335633A/en unknown
- 1997-12-05 EP EP97954525A patent/EP0964699A4/en not_active Withdrawn
- 1997-12-05 BR BR9714133-0A patent/BR9714133A/en not_active IP Right Cessation
- 1997-12-05 AR ARP970105740A patent/AR010337A1/en not_active Application Discontinuation
- 1997-12-05 JP JP52575898A patent/JP2001510992A/en active Pending
- 1997-12-05 EE EEP199900226A patent/EE9900226A/en unknown
-
1999
- 1999-05-04 NO NO992158A patent/NO992158L/en not_active Application Discontinuation
- 1999-05-10 IS IS5047A patent/IS5047A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO992158L (en) | 1999-07-05 |
| KR20000069297A (en) | 2000-11-25 |
| IL129746A0 (en) | 2000-02-29 |
| NO992158D0 (en) | 1999-05-04 |
| TR199901262T2 (en) | 1999-08-23 |
| EP0964699A1 (en) | 1999-12-22 |
| IS5047A (en) | 1999-05-10 |
| NZ335633A (en) | 2000-10-27 |
| EE9900226A (en) | 1999-12-15 |
| BR9714133A (en) | 2000-02-29 |
| SK57999A3 (en) | 2000-05-16 |
| AU5895498A (en) | 1998-06-29 |
| ID21946A (en) | 1999-08-12 |
| JP2001510992A (en) | 2001-08-07 |
| EP0964699A4 (en) | 2005-04-06 |
| CN1246799A (en) | 2000-03-08 |
| WO1998024475A1 (en) | 1998-06-11 |
| AU739641B2 (en) | 2001-10-18 |
| PL333943A1 (en) | 2000-01-31 |
| CA2273199A1 (en) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adermann et al. | Structural and phylogenetic characterization of human SLURP‐1, the first secreted mammalian member of the Ly‐6/uPAR protein superfamily | |
| Denkewalter et al. | Total synthesis of an enzyme. I. Objective and strategy | |
| ES2054878T3 (en) | EXPRESSION OF PROAPOLIPOPROTEIN A-I HUMAN. | |
| AR010337A1 (en) | ISOLATED NUCLEIC ACID, NUCLEIC ACID MOLECULA, PROBE, RECOMBINANT EXPRESSION VECTOR, CELL, METHOD FOR PRODUCING A POLYPEPTIDE OF H.PYLORI, METHOD FOR DETECTING THE PRESENCE OF A NUCLEIC ACID HELICOBACTER, POLIPE FORMULATION FOR VACCINE | |
| Delbac et al. | On proteins of the microsporidian invasive apparatus: complete sequence of a polar tube protein of Encephalitozoon cuniculi | |
| BR9408006A (en) | Isolated and purified nucleic acid molecule vector and expression vector adapted for transformation of host host transformed recombinant transferrin receptor protein or fragment or analogue of the same purified and isolated Tbpl protein, purified and isolated Tbp2 protein, peptide, active vector composition for delivery receptor protein "transferrin" plasmid vector haemophilus lineage process to produce purified and isolated Tbp2 or Tbpl protein | |
| DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
| Graf et al. | Cathepsin D generates γ-endorphin from β-endorphin | |
| BR9712587A (en) | Nucleic acid, nucleic acid molecule, probe, recombinant expression vector, cell, processes for producing an h. pylori and to detect the presence of a helicobacter pylori nucleic acid in a sample, h. pylori isolated, cell, cellular and secreted envelope polypeptides from h. pylori or fragments thereof, fusion protein, vaccine formulation for the prophylaxis or treatment of an h. pylori, and processes to treat or reduce a risk of h. pylori in a subject and to produce a vaccine formulation. | |
| DE69233245D1 (en) | Process for the preparation of peptides | |
| ATE357526T1 (en) | MODIFIED HCV PEPTIDE VACCINES | |
| CA2353802A1 (en) | New protective antigen of group a streptococci | |
| BR9908476A (en) | Peptide, therapeutic composition, and, process to confer protective immunity to a patient, against s infection. pneumoniae | |
| ATE274059T1 (en) | TRANSFERRIN RECEPTOR GENES | |
| DK595187A (en) | MINACTIVIN AND METHOD OF PRODUCING THEREOF | |
| US5573943A (en) | Cloning and expression of a rhoptry associated protein of P. falciparum | |
| NZ512308A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
| ATE129504T1 (en) | ALLELIC VARIANTS OF -I(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN. | |
| BR9506666A (en) | Construction of expression vector DNA the replicable process for the preparation of an attenuated bacterium host cell vaccine composition and process for the treatment or prophylaxis of an infection in a mammal for example a human | |
| AR010209A1 (en) | ISOLATED NUCLEIC ACID UNDERSTANDING A SEQUENCE CODING A H.PYLORI POLYPEPTIDE, A RECOMBINANT EXPRESSION VECTOR, A CELL COMPRISING ESEVECTOR, A METHOD FOR THE PRODUCTION OF A COMPACT OF A DIPHLORI OF VACCINE FOR | |
| AR030293A1 (en) | A VACCINE COMPOSITION THAT INCLUDES AN FC RECEIVING PROTEIN; A METHOD TO PREPARE IT; USE OF SUCH PROTEIN AND A POLINUCLEOTIDE THAT CODIFIES FOR SUCH PROTEIN AND A METHOD TO TREAT OR PREVENT A BACTERIAL INFECTION | |
| MX9709527A (en) | Transferrin receptor genes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |